Published on 18 Feb 2024 on Simply Wall St. via Yahoo Finance
Strong week for Standard BioTools (NASDAQ:LAB) shareholders doesn't alleviate pain of five-year loss
Standard BioTools Inc. (NASDAQ:LAB) shareholders should be happy to see the share price up 14% in the last month. But spare a thought for the long term holders, who have held the stock as it bled value over the last five years. Like a ship taking on water, the share price has sunk 76% in that time. It's true that the recent bounce could signal the company is turning over a new leaf, but we are not so sure. The million dollar question is whether the company can justify a long term recovery.
On a more encouraging note the company has added US$52m to its market cap in just the last 7 days, so let's see if we can determine what's driven the five-year loss for shareholders.
View our latest analysis for Standard BioTools